Kura Oncology, Inc. (KURA) stock down despite upgrade at Zacks Investment Research

Kura Oncology, Inc. (NASDAQ: KURA) shares slid back in value in early trading today on lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

U.S. stocks flipped between small losses and gains early Tuesday morning as investors maintained a cautious stance following a sharp postelection rally.

The S&P 500 index SPX, -0.04% was off by about 1 point, or less than 0.1%, at 2,267, with seven of the 11 main sectors trading lower. The Dow Jones Industrial Average DJIA, -0.13% was off 33 points, or 0.2%, to 19,853.

Meanwhile, the Nasdaq Composite Index COMP, +0.05% traded in record territory, after closing at an all-time high for the second session in a row on Monday.

Analysts at Zacks Investment Research upgraded shares of Kura Oncology, Inc. (NASDAQ: KURA) from Hold to Buy today. With a rating of Buy on the shares, the company has a 52-week high of $7.89. As a means of comparison, a number of other analysts have issued reports on the company recently, and Kura Oncology, Inc. has earned a consensus one-year price target of $17.00, higher than the opening price of $6.20, a difference of 27.20 percent. Stock prices sometimes get a boost to the upside when analysts upgrade a stock.

Shares of Kura Oncology, Inc. (NASDAQ: KURA) opened at $6.20 yesterday trading between $6.15 and $6.25, and last traded at $6.25, a decrease of $0.01 compared to the previous closing price.

Kura Oncology, Inc. (NASDAQ: KURA) now has a market cap of 118.94M.

Kura Oncology, Inc. (NASDAQ: KURA) Average Daily Trading Volume

2,115 shares crossed the trading desk yesterday, 24 percent lower than the norm, out of a total float 10,917,000. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use swings in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for short periods will not mean much will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain teams of analysts researching thousands of stocks. So watching their interests is a good way to make sure you are buying the right stocks.

Kura Oncology, Inc. (NASDAQ: KURA) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

Trades for Kura Oncology, Inc. (NASDAQ: KURA) have ranged from $2.50 – 7.890, and the stock now has a 50-day MA of $5.64 and 200-day MA of $5.10. Today’s last price is 20.85%% lower than the 52 week high of $7.89.

Earnings growth is a critical factor to consider when investing in stocks and investors watch for companies that have grown their earnings by at least 25% over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *